SLA Pharma is a niche biopharmaceutical company, specializing in gastrointestinal and allied disorders, with products in clinical development and already approved for human use. SLA Pharma is committed to improving the range of products available to treat gastrointestinal diseases worldwide. SLA Pharma AG is one of the few pharmaceutical companies in the world focused solely on developing medicines for the prevention and treatment of gastrointestinal (GI) disorders. This commitment to developing solutions for GI disorders has made SLA Pharma a world leader in the field through unrivalled development, medical, regulatory and commercial expertise in its therapeutic areas.
| Website | http://www.slapharma.com |
| Revenue | $5.8 million |
| Employees | 9 (8 on RocketReach) |
| Founded | 1997 |
| Phone | +41 61 588 00 12 |
| Technologies |
JavaScript
,
HTML
,
PHP
+20 more
(view full list)
|
| Industry | Pharmaceutical Manufacturing, Manufacturing General, Medical, Gastrointestinal, Manufacturing, Health Care, Licensing, Pharmaceutical, Digestive, Anal Fissure, Crohn's disease, Familial Adenomatous Polyposis, Constipation, Gastroenterology, Specialty Pharmaceuticals, Orphan Diseases, Alimentary, Partnering, Opioid Induced, FAP, Rectal, Business Development, Niche, Bowel, Cancer |
| Web Rank | 14 Million |
| Keywords | Pharmaceutical, Biopharmaceutical, Gastrointestinal Disorders, Biotechnology, Gastroenterology, Digestive Health, Clinical Development, Drug Development, Pharmaceutical Products, Pharmaceutical Research, Human Health, New Drugs, Medicinal Products, Prescription Drugs |
| Competitors | Johnson & Johnson, Roche, Novartis, AbbVie, Pfizer, Bristol Myers Squibb, Amgen, Teva Pharmaceuticals, Sandoz, Mylan Belgium +44 more (view full list) |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 325 Companies, NAICS Code 32541 Companies, NAICS Code 32 Companies, NAICS Code 3254 Companies |
Looking for a particular SLA Pharma employee's phone or email?
SLA Pharma Questions
The SLA Pharma annual revenue was $5.8 million in 2026.
Justin Slagel is the CEO of SLA Pharma.
8 people are employed at SLA Pharma.
The NAICS codes for SLA Pharma are [325, 32541, 32, 3254].
The SIC codes for SLA Pharma are [28, 283].
Top SLA Pharma Employees
-
Justin Slagel
CEO at SLA Pharma
Watford, GB13 -
Clifton Flack
Chief Commercial Officer (CCO) at SLA Pharma
United Kingdom21 -
Chris Jordan
Medical Director at SLA Pharma
Watford, GB13 -
Mia Yaniv
Product Development Manager at SLA Pharma
United Kingdom1 -
Laura Nachoom-Slagel
Human Resources Manager at SLA Pharma
Borehamwood, GB -
Catherine Connor
Pa to CEO at SLA Pharma
Hemel Hempstead, GB2
